INDV Earnings Prediction
The chart below shows how INDV performed 10 days before and after its earnings report, based on data from the past quarters. Typically, INDV sees a +1.03% change in stock price 10 days leading up to the earnings, and a +4.40% change 10 days following the report. On the earnings day itself, the stock moves by +1.35%. This data can give you a slight idea of what to expect for the next quarter's release.
INDV Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
307.00M
13.28%
2.68%
Gross Margin
80.78%
-2.71%
-2.22%
Operating Margin
30.62%
45.60%
20.46%
Net Margin
1.30%
102.61%
-103.63%
EPS
0.03
103.06%
-103.80%
No Data Available
INDV Earnings Analysis
Indivior PLC Ordinary Shares Corporation (INDV.O) Earnings Conference Call
Positive
Third Quarter Revenue Increase: SUBLECADE third quarter net revenue of $191 million increased 14%, primarily driving the 13% increase in total third quarter net revenue to $307 million.
Operating Profit Surge: Adjusted operating profit through the quarter increased 62% to $97 million, and our cash position at the end of the third quarter was $344 million.
New Patient Share: SUBLECADE's share of new patients was 72% at the end of the third quarter.
Expense Increase Analysis: U.S. SUBLOCADE expenses of $158,500 in the third quarter increased 19% versus last year and 2% versus the prior quarter.
Operating Income Surge: Adjusted operating income of $97 million in the third quarter was up 62% versus the prior year, mainly benefiting from solid growth in the U.S. net revenue and lower overall operating expenses.
Negative
Growth Challenges and Competition: SUBLEADER's growth is being impacted by a combination of intensified initial trial and adoption of the competing product, variability in funding, timing in certain justice system accounts, and further destocking.
Market Share Decline: SUBLEADER's share of new patients was 72% at the end of the third quarter, indicating a decline in market share.
Expense Increase Analysis: SUBLEADER's expenses of $158,500 in the third quarter increased 19% versus last year and 2% versus the prior quarter, reflecting rising operational costs.
Trade Destocking Impact: The difference between the sequential dispense growth of 2% and the modest 1% decline in net revenue is due to trade destocking in the third quarter.
Gross Margin Decline: SUBLEADER's adjusted gross margin of 82% was down sequentially and versus the prior year quarter, reflecting unfavorable pricing on specific production batches.
INDV FAQs
How does INDV typically perform around its earnings report dates?
Is Indivior PLC (INDV) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
INDV Earning Call Sentiment
Indivior PLC (INDV) Q3 2024 Earnings Call Transcript
INDV.O
-1.92%Positive
The earnings call indicates strong financial performance with significant revenue and net income growth. Despite some concerns such as pipeline risks and gross margin decline, the positive aspects like the successful share buyback program, strong cash position, and optimistic guidance for SUBLOCADE overshadow them. The Q&A further supports a positive outlook with encouraging data on new patient share and strategic focus on SUBLOCADE. Given the market cap, the stock is likely to see a positive movement of 2% to 8% over the next two weeks.
